Divisiong of Nephrology and Hypertension

 

 

 

Sharon Anderson, M.D.

Sharon Anderson, M.D.
Professor of Medicine
Chair, Department of Medicine
Email: dom@ohsu.edu

Back to faculty page

 

 

Sharon Anderson, M.D.

Dr. Anderson is the Chair for the OHSU Department of Medicine.

Degrees:

B.A., University of Maryland 1971
M.D., Louisiana State University Medical Center 1979

Residency:

Internal Medicine, Oregon Health Sciences University 1979-1982

Fellowship:

Nephrology - Beth Israel Hospital and Harvard Medical School, 1982-1983
Nephrology Research - Brigham and Women's Hospital and Harvard Medical School, 1983-1985

Research Interest:
  • Hypertension and the kidney, Pathophysiology of the aging kidney, Diabetic nephropathy
  • Hormonal modulation of renal function, and Mechanisms of progressive glomerular injury.
Clinical Interest:

Acute and chronic renal failure, hypertension, diabetic nephropathy.

Representative Publications:
  • Anderson S, Jung FF, Ingelfinger JR. Renin-angiotensin system in diabetic rats: functional, immunohistochemical, and molecular biologic correlations. Am J Physiol 265:F477-F486, 1993
  • Kang D-H, Anderson S, Kim Y-G, Mazzali M, Suga S-I, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37:601-611, 2001
  • Komers R, Lindsley JN, Oyama TT, Schutzer WE, Reed JF, Mader SL, Anderson S. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest 197:889-898, 2001. Download PDF
  • Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver E, Woolard NF, High KP.  Prediction, progression, and outcomes of chronic kidney disease in older adults.  J Am Soc Nephrol 20: 1199–1209, 2009
  • Stringer KD, Komers R, Osman SA, Oyama TT, Lindsley JN, Anderson S.  Gender hormones and the progression of experimental polycystic kidney disease.  Kidney Int 68:1729-1739, 2005
  • Anderson S, Eldadah B, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kimmel P, Molitoris BA, Murthy M, O’Hare AM, Schmader K, High KP.  Workshop on acute kidney injury in older adults.  J Am Soc Nephrol 22: 28–38, 2011
  • Hutchens MP, Fujiyoshi T, Komers R, Herson PS, Anderson S.  Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo.  Am J Physiol Renal Physiol Am J Physiol Renal Physiol 303:F377-F385, 2012
  • Anderson S, Oyama TT, Lindsley JN, Schutzer WE, Beard DR, Komers R.  2-hydroxyestradiol slows progression of experimental polycystic kidney disease.  Am J Physiol Renal Physiol 302:F636-F645, 2012
  • Rao MK, Morris CD, Davis MM, O’Malley JP, Mori M, Anderson S.  Documentation and management of CKD in rural primary care.  Clin J Am Soc Nephrol 8:739-748, 2013